Cat.#: ACPP-1244
| Despition | SOX2 Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1523 | RPE65 Blocking Peptide (AC1523) | 250 µg | inquiry |
| ACPP-1238 | LIMK1 Blocking Peptide (AC1238) | 250 µg | inquiry |
| ACPP-1687 | Mouse Visfatin Protein (AC1687) | 5 µg | inquiry |
| ACPP-1711 | Human PEBP1 Protein (AC1711) | 10 µg | inquiry |
| ACPP-1221 | Bestrophin Blocking Peptide (AC1221) | 250 µg | inquiry |
| ACPP-1073 | Dopamine D5 Receptor Blocking Peptide (AC1073) | 250 µg | inquiry |
| ACPP-1558 | Human ALK/P80 Protein (AC1558) | 2 µg | inquiry |
| ACPP-1030 | Recombinant Human Acetylcholinesterase Protein (6×His Tag) (AC1030) | 50 µg | inquiry |
| ACPP-1062 | Recombinant Human TYRO3 Protein (Fc Tag) (AC1062) | 50 µg | inquiry |
| ACPP-1325 | Synaptotagmin 1 Blocking Peptide (AC1325) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.